NQO1 and neoplasm: He et al. constructed rectangular DNA origami nanostructures of an amsacrine prodrug with tumor-targeting specificity enzyme (NQO1), which showed therapeutic selectivity towards NQO1-overexpressing MCF-7 cells and healthy L02 cells (He et al., 2023).